Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer

Malgorzata K Tuxen; Soeren Cold; Ulla B Tange; Eva Balslev; Dorte L Nielsen

doi:10.3109/0284186X.2014.921727

Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer

Malgorzata K Tuxen, Soeren Cold, Ulla B Tange, Eva Balslev, Dorte L Nielsen

Department of Clinical Medicine

10 Citations (Scopus)

Original language	English
Journal	Acta Odontologica Scandinavica
Volume	53
Issue number	10
Pages (from-to)	1440-1445
Number of pages	6
ISSN	0001-6357
DOIs	https://doi.org/10.3109/0284186X.2014.921727
Publication status	Published - 1 Oct 2014

Keywords

Adult
Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Cyclophosphamide
Doxorubicin
Drug Administration Schedule
Feasibility Studies
Female
Humans
Middle Aged
Neoadjuvant Therapy
Polyethylene Glycols
Receptor, ErbB-2
Receptors, Estrogen
Sample Size
Taxoids

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/0284186X.2014.921727

Cite this

Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer. / Tuxen, Malgorzata K; Cold, Soeren; Tange, Ulla B et al.

In: Acta Odontologica Scandinavica, Vol. 53, No. 10, 01.10.2014, p. 1440-1445.

Research output: Contribution to journal › Comment/debate › Research › peer-review

@article{ae96f330de5a475fb6856e416f8af874,

title = "Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer",

keywords = "Adult, Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Cyclophosphamide, Doxorubicin, Drug Administration Schedule, Feasibility Studies, Female, Humans, Middle Aged, Neoadjuvant Therapy, Polyethylene Glycols, Receptor, ErbB-2, Receptors, Estrogen, Sample Size, Taxoids",

author = "Tuxen, {Malgorzata K} and Soeren Cold and Tange, {Ulla B} and Eva Balslev and Nielsen, {Dorte L}",

year = "2014",

month = oct,

day = "1",

doi = "10.3109/0284186X.2014.921727",

language = "English",

volume = "53",

pages = "1440--1445",

journal = "Acta Odontologica Scandinavica",

issn = "0001-6357",

publisher = "Taylor & Francis",

number = "10",

}

TY - JOUR

T1 - Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer

AU - Tuxen, Malgorzata K

AU - Cold, Soeren

AU - Tange, Ulla B

AU - Balslev, Eva

AU - Nielsen, Dorte L

PY - 2014/10/1

Y1 - 2014/10/1

KW - Adult

KW - Aged

KW - Antibodies, Monoclonal, Humanized

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Breast Neoplasms

KW - Cyclophosphamide

KW - Doxorubicin

KW - Drug Administration Schedule

KW - Feasibility Studies

KW - Female

KW - Humans

KW - Middle Aged

KW - Neoadjuvant Therapy

KW - Polyethylene Glycols

KW - Receptor, ErbB-2

KW - Receptors, Estrogen

KW - Sample Size

KW - Taxoids

U2 - 10.3109/0284186X.2014.921727

DO - 10.3109/0284186X.2014.921727

M3 - Comment/debate

C2 - 24991893

SN - 0001-6357

VL - 53

SP - 1440

EP - 1445

JO - Acta Odontologica Scandinavica

JF - Acta Odontologica Scandinavica

IS - 10

ER -